Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

• Moffat J Nyirenda,
• Beverley M Shields,
• Andrew T Hattersley,
• Angus G Jones,
• Lauren R Rodgers,
• Anxious J Niwaha,
• Priscilla A Balungi,
• Raymond Mwebaze,
• Alice L J Carr

Affiliations

Moffat J Nyirenda

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda

Beverley M Shields

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK

Andrew T Hattersley

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK

Angus G Jones

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK

Lauren R Rodgers

Institute of Health Research, University of Exeter Medical School, Exeter, UK

Anxious J Niwaha

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK

Priscilla A Balungi

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK

Raymond Mwebaze

Department of Medicine, St. Francis Hospital Nsambya, Kampala, Uganda

Alice L J Carr

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK